International Seminar Series on Liver Toxicity and Steatotic Liver Disease

Good morning,

We are pleased to announce that the International Seminar Series on Liver Toxicity and Steatotic Liver Disease is back for another year! After a brief pause, we are resuming our monthly sessions to continue fostering knowledge exchange and collaboration in this important field.

Our next session will take place on Wednesday, 16th April, from 16:30h to 17:30h (CEST). Your participation is key to enriching the discussions, and we look forward to hearing your insights.

Thank you for being part of this initiative—we hope to see you there!

DATE: 16th April at 16:30h (CEST)

GUEST: Dr. Volker Lauschke

REGISTRATION AT THIS LINK:

Volker M. Lauschke is Professor in Translational Pharmacology at Karolinska Institutet, Stockholm and Deputy Head of the Bosch Institute of Clinical Pharmacology in Stuttgart, Germany. In addition, he holds Guest Professorships at the Second Xiangya Hospital, Central South University and at Lanzhou University, China. Besides his academic work, he is co-founder and CEO of HepaPredict AB as well as co-founder of Shanghai Hepo Biotechnology Ltd, which provide innovative 3D human tissue cultures for drug discovery and development.

In this talk, he will present an overview of how 3D cell culture systems of primary human cells and microfluidics can be integrated with phenotypic and chemogenomic screening to identify novel targets for steatotic liver disease.

Coordinators EASL DHILI Consortium: Marina Villanueva Paz & Ann Daly

Members of the Educational activities committee: Anna Licata (Italy), Jane Grove (UK), Lilliana Liliana Mititelu-Tartau (Romania), Irina Milisav (Slovenia), Helena Glasova (Slovakia)

Coordinators HALT-RONIN: Francisco Javier Cubero & Joana Miranda

Certificate of attendance will be provided on request. If you know of someone who would be interested in attending this Conference, please forward this email.

Looking forward to welcoming you at this important event